Nutrition, exercise, and complementary medicine: potential role in mesothelioma?

被引：0
作者：
Sanjeevan Muruganandan
Emily Jeffery
Carolyn McIntyre
Y. C. Gary Lee
机构：
[1] Sir Charles Gairdner Hospital,Department of Respiratory Medicine
[2] University of Western Australia,School of Medicine & Pharmacology
[3] Institute of Respiratory Health,Pleural Medicine Unit
[4] Edith Cowan University,School of Exercise and Health Sciences
来源：
Current Pulmonology Reports | 2016年 / 5卷 / 1期
关键词：
Mesothelioma; Complementary medicine; Nutrition; Exercise; Diet; Palliative care;
D O I：
10.1007/s13665-016-0133-0
中图分类号：
学科分类号：
摘要：
Malignant pleural mesothelioma (MPM) is an aggressive malignancy arising from the pleura and caused predominantly by inhaled asbestos fibers. Prognosis is poor and treatment options are with a palliative intent. Patients with MPM have a high symptom burden; therefore, the relief or control of these symptoms is paramount to improving quality of life (QoL). Malnutrition is also a common concern in this group and may have prognostic significance. Alternative approaches such as nutritional intervention, physical activity, and complementary medicine may have further benefits as adjuncts to current best supportive care for patients with MPM. The body of research into these therapies in cancer and other chronic health conditions continues to grow. However, their roles in MPM await exploration.
引用
收藏
页码：20 / 27
页数：7
相关论文
共 314 条
[1]  
Robinson BWS(2005)Malignant mesothelioma Lancet 366 397-408
[2]  
Musk AW(2005)The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050 Br J Cancer 92 587-44
[3]  
Lake RA(2011)Global magnitude of reported and unreported mesothelioma Environ Health Perspect 119 514-1
[4]  
Hodgson JT(2003)Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma J Clin Oncol 21 2636-72
[5]  
McElvenny DM(2014)Surgical resection of mesothelioma: an evidence-free practice Lancet 384 1080-27
[6]  
Darnton AL(2011)Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study Lancet Oncol 12 763-32
[7]  
Price MJ(2014)Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial Lancet 384 1118-80
[8]  
Peto J(2010)Respiratory chest pain: diagnosis and treatment Med Clin N Am 94 217-73
[9]  
Park EK(2004)Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module J Clin Oncol 22 3172-13
[10]  
Takahashi K(2012)Postmortem findings of malignant pleural mesothelioma: a two-center study of 318 patients Chest 142 1267-7
12345678910